In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi

被引:40
作者
Garcia-Effron, G [1 ]
Gomez-Lopez, A [1 ]
Mellado, E [1 ]
Monzon, A [1 ]
Rodriguez-Tudela, JL [1 ]
Cuenca-Estrella, M [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Madrid 28220, Spain
关键词
Aspergillus spp; Spanish filamentous fungi; allylamines; antifungals;
D O I
10.1093/jac/dkh228
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The activity in vitro of terbinafine against 442 clinical isolates of several species of filamentous fungi was analysed. Methods: A broth microdilution test was carried out following the National Committee for Clinical Laboratory Standards reference method, with modifications described previously. Results: The geometric mean (GM) of MICs of terbinafine for non-Aspergillus fumigatus species was 0.24 mg/L whereas the GM for A. fumigatus rose as far as 2.92 mg/L. Terbinafine showed a very strong activity in vitro against Penicillium spp., Paecilomyces spp., Trichoderma spp., Acremonium spp. and Arthrographis spp. with GMs <1 mg/L. However, some species such as Scedosporium spp., Fusarium spp., Scopulariopsis brevicaulis, and most of Mucorales exhibited high MICs of the allylamine with GMs greater than or equal to 4 mg/L. Conclusions: Overall, the GM of MICs of terbinafine was 1.57 mg/L, but significant differences in susceptibilities were seen between genera and species.
引用
收藏
页码:1086 / 1089
页数:4
相关论文
共 14 条
[11]   Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi [J].
Rodriguez-Tudela, JL ;
Chryssanthou, E ;
Petrikkou, E ;
Mosquera, J ;
Denning, DW ;
Cuenca-Estrella, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5236-5237
[12]   Refractory pulmonary aspergillosis: Compassionate trial with terbinafine [J].
Schiraldi, GF ;
LoCicero, S ;
Colombo, MD ;
Rossato, D ;
Ferrarese, M ;
Soresi, E .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 :25-29
[13]   Combination and sequential antifungal therapy for invasive aspergillosis: Review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001 [J].
Steinbach, WJ ;
Stevens, DA ;
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S188-S224
[14]   Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases [J].
Tosti, A ;
Piraccini, BM ;
Lorenzi, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (02) :217-224